Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Backx

Showing results (531-540 of 585) with videos related to

Pageof 59
Sort By:
Journal of Medical Genetics|February 24, 2006
Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reportsB Menten, N Maas, B Thienpont, et al.
Thrombosis and Haemostasis|May 1, 2015
Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The X-PLORER trialP Vranckx, F W G Leebeek, J G P Tijssen, et al.
The International Journal of Behavioral Nutrition and Physical Activity|June 27, 2018
The 2017 Dutch Physical Activity GuidelinesRianne M Weggemans, Frank J G Backx, Lars Borghouts, et al.
Pediatric Cardiology|December 3, 2016
Six-Minute Walk Test as a Predictor for Outcome in Children with Dilated Cardiomyopathy and Chronic Stable Heart FailureSusanna L den Boer, Daniël H K Flipse, Marijke H van der Meulen, et al.
Mitochondrion|November 21, 2012
A multi-center comparison of diagnostic methods for the biochemical evaluation of suspected mitochondrial disordersR J T Rodenburg, G C Schoonderwoerd, V Tiranti, et al.
Biomaterials|August 31, 2023
Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutationMarianne Wauchop, Naimeh Rafatian, Yimu Zhao, et al.
Nature|June 21, 2002
Angiotensin-converting enzyme 2 is an essential regulator of heart functionMichael A Crackower, Renu Sarao, Gavin Y Oudit, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?Francesco Costa, Salvatore Brugaletta, Alberto Pernigotti, et al.
Circulation|March 3, 2004
Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel diseaseVictor M G Legrand, Patrick W Serruys, Felix Unger, et al.
American Journal of Human Genetics|April 23, 2019
Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and HypogonadismHilde Van Esch, Rita Colnaghi, Kathleen Freson, et al.
Pageof 59

Showing results (531-540 of 585) with videos related to

Sort By:
Pageof 59
Journal of Medical Genetics|February 24, 2006
Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reportsB Menten, N Maas, B Thienpont, et al.
Thrombosis and Haemostasis|May 1, 2015
Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The X-PLORER trialP Vranckx, F W G Leebeek, J G P Tijssen, et al.
The International Journal of Behavioral Nutrition and Physical Activity|June 27, 2018
The 2017 Dutch Physical Activity GuidelinesRianne M Weggemans, Frank J G Backx, Lars Borghouts, et al.
Pediatric Cardiology|December 3, 2016
Six-Minute Walk Test as a Predictor for Outcome in Children with Dilated Cardiomyopathy and Chronic Stable Heart FailureSusanna L den Boer, Daniël H K Flipse, Marijke H van der Meulen, et al.
Mitochondrion|November 21, 2012
A multi-center comparison of diagnostic methods for the biochemical evaluation of suspected mitochondrial disordersR J T Rodenburg, G C Schoonderwoerd, V Tiranti, et al.
Biomaterials|August 31, 2023
Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutationMarianne Wauchop, Naimeh Rafatian, Yimu Zhao, et al.
Nature|June 21, 2002
Angiotensin-converting enzyme 2 is an essential regulator of heart functionMichael A Crackower, Renu Sarao, Gavin Y Oudit, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?Francesco Costa, Salvatore Brugaletta, Alberto Pernigotti, et al.
Circulation|March 3, 2004
Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel diseaseVictor M G Legrand, Patrick W Serruys, Felix Unger, et al.
American Journal of Human Genetics|April 23, 2019
Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and HypogonadismHilde Van Esch, Rita Colnaghi, Kathleen Freson, et al.
Pageof 59